Detalles de la búsqueda
1.
A Randomized Phase II Study of Eribulin/Cyclophosphamide or Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Operable HER2-negative Breast Cancer.
Clin Breast Cancer
; 19(1): 1-9, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30245148
2.
Regorafenib Prior to Selective Internal Radiation Therapy Using 90Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety, Dosimetry, and Molecular Markers.
Front Oncol
; 9: 624, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31355141
3.
Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium.
Lung Cancer
; 117: 38-43, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29496254
4.
Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Operable Breast Cancer: A Phase II Trial of the Sarah Cannon Research Institute.
Clin Breast Cancer
; 15(4): 251-8, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25640059
5.
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancer.
Lung Cancer
; 78(1): 70-5, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22947511
6.
A phase II trial of dose-dense neoadjuvant gemcitabine, epirubicin, and albumin-bound paclitaxel with pegfilgrastim in the treatment of patients with locally advanced breast cancer.
Clin Breast Cancer
; 10(5): 367-72, 2010 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20670921
7.
Phase II study of biweekly pemetrexed and gemcitabine in patients with previously untreated advanced non-small cell lung cancer.
J Thorac Oncol
; 5(6): 841-5, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20421819
8.
Phase II trial of irinotecan, carboplatin, and bevacizumab in the treatment of patients with extensive-stage small-cell lung cancer.
J Thorac Oncol
; 4(12): 1555-60, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19875975
Resultados
1 -
8
de 8
1
Próxima >
>>